The CBD cannabinoid is becoming increasingly popular for its medical applications
Cannabidiol (CBD) is one of the two most important cannabinoid components of the cannabis plant. One of the great advantages that many people like is that it does not produce any psychoactive effect. However, it is complemented by tetrahydrocannabinol (THC) to compensate its effects and have greater efficacy. CBD continues to receive a lot of support due to its proven ability to offer substantial relief for a number of health issues.
Currently, CBD is the cannabinoid that is recognized as having the most beneficial effects for the treatment of some symptoms and diseases, and with the greatest therapeutic margin. There are many studies that investigate and demonstrate the possible benefits of CBD in our health. Among those that stand out are its effects: anti-epileptic, thus improving the severity and frequency of epileptic seizures; cancer cell growth slowing down, stopping their propagation, for example, in breast cancer; or anti-psychotic and anxiolytic, reducing the symptoms of post-traumatic stress and anxiety.
One of the reasons why CBD is highly sought after is its ability to reduce pain in general. Different studies have shown that CBD has an analgesic and anxiolytic effect in preclinical models of chronic neuropathic pain, well-validated by the international scientific literature. On the one hand, a certain anti-inflammatory efficacy has been highlighted, which represents one of the components considered important in this pathology. On the other hand, its action on neurotransmissions such as serotonin could explain its pharmacological effects also on those neuropsychiatric components associated with neuropathic pain.
Moreover, it has also been shown that CBD is very useful to elevate the mood and reduce depression. According to studies, CBD would act on serotonin levels in the brain. Serotonin is a neuromodulator of the human nervous system and regulates mood, perception, reward, anger, aggression, appetite, or memory. Stress is one of the main factors that reduce serotonin concentration and its metabolism is associated with several psychiatric disorders.